VK
Viking Therapeutics
VKTX · NASDAQ
$32.70 -1.98% (-$0.66)
1M -3.25%
Market Cap $3.81B
P/E Ratio -
Div. Yield -
ROE 94.56%
Bulios Fair Price
$30.74
6.0% downside
Trenutna cena
$32.7
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VKTX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 9.34x
EV/FFO N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 63.83%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 94.56%
ROA 102.47%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 4.72x
Int. coverage -66,848.50x
Debt/Equity 0.01x
Stability
37 /100
Moderate EPS volatility 120.52%
Profitable years 0
Beta 0.68x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VKTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Brian Lian
Employees
65
Headquarters
San Diego
Prihajajoči dogodki
28 OKT.
Earnings
Upcoming earnings report